TWO SIGMA ADVISERS, LP - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 198 filers reported holding SEATTLE GENETICS INC in Q3 2013. The put-call ratio across all filers is 2.26 and the average weighting 0.2%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q2 2020$3,670,000
+4.6%
21,600
-29.6%
0.01%
+37.5%
Q4 2019$3,508,000
+70.5%
30,700
+27.4%
0.01%
+60.0%
Q3 2019$2,058,000
+98.3%
24,100
+31.5%
0.01%
+66.7%
Q4 2018$1,038,000
-92.4%
18,322
-89.7%
0.00%
-90.9%
Q3 2018$13,698,000
+124.0%
177,624
+52.0%
0.03%
+94.1%
Q1 2018$6,115,000
-38.4%
116,824
-37.1%
0.02%
-37.0%
Q4 2017$9,931,000
+54.1%
185,624
+56.7%
0.03%
+50.0%
Q3 2017$6,443,000
-50.8%
118,424
-53.2%
0.02%
-58.1%
Q2 2017$13,086,000
-49.7%
252,923
-38.9%
0.04%
-49.4%
Q1 2017$26,019,000
+26.7%
413,924
+6.3%
0.08%
+7.6%
Q4 2016$20,539,000
+204.2%
389,222
+211.3%
0.08%
+172.4%
Q3 2016$6,752,000
+10.4%
125,022
-17.4%
0.03%
-6.5%
Q2 2016$6,115,000
+406.2%
151,322
+339.6%
0.03%
+342.9%
Q1 2016$1,208,000
-20.8%
34,422
+9.2%
0.01%
-41.7%
Q2 2015$1,526,000
+137.3%
31,522
+57.4%
0.01%
+140.0%
Q4 2014$643,000
+55.3%
20,022
+80.0%
0.01%
+66.7%
Q3 2014$414,000
+53.9%
11,122
+58.4%
0.00%
+50.0%
Q2 2014$269,000
-49.6%
7,022
-40.1%
0.00%
-60.0%
Q1 2014$534,000
+130.2%
11,722
+101.3%
0.01%
+150.0%
Q4 2013$232,000
-45.9%
5,822
-57.3%
0.00%
-66.7%
Q2 2013$429,00013,6430.01%
Other shareholders
SEATTLE GENETICS INC shareholders Q3 2013
NameSharesValueWeighting ↓
Baker Brothers Advisors 45,725,556$2,365,840,00020.68%
Lagoda Investment Management, L.P. 398,529$20,620,0007.88%
Matrix Capital Management Company, LP 2,118,000$109,585,0003.72%
Ghost Tree Capital, LLC 300,000$15,522,0003.23%
Sio Capital Management, LLC 100,000$5,174,0002.46%
GREAT POINT PARTNERS LLC 249,500$12,909,0002.31%
Redmile Group, LLC 665,139$34,414,0002.10%
Eventide Asset Management 525,000$27,164,0001.69%
Opus Point Partners Management, LLC 35,093$1,816,0001.66%
Boxer Capital, LLC 125,000$6,468,0001.54%
View complete list of SEATTLE GENETICS INC shareholders